Researcher
Sandrine Aspeslagh
- Keywords:Medicine
Affiliations
- Internal medicine (Department)
Member
From1 May 2023 → Today - Laboratory for Medical and Molecular Oncology (Research group)
Member
From22 Mar 2021 → Today - Medical Oncology (Department)
Member
From1 Feb 2019 → Today - Clinical sciences (Department)
Member
From1 Feb 2021 → Today - Clinical sciences (Department)
Member
From1 Feb 2021 → 20 Oct 2022 - Clinical sciences (Department)
Member
From15 Nov 2020 → 14 Nov 2022
Projects
1 - 1 of 1
- FORX - FOod interventions to Reduce immunotherapy toXicityFrom1 Nov 2023 → TodayFunding: FWO fellowships
Publications
31 - 40 of 71
- How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?(2019)
Authors: Luís Castelo-Branco, Sandrine Aspeslagh, Nuria Kotecki, Ahmad Awada
Pages: 420-423 - Immune checkpoint inhibitors and type 1 diabetes mellitus(2019)
Authors: Jeroen M.K. de Filette, Joeri Pen, Lore Decoster, Thomas Vissers, Bert Bravenboer, Bart J Van der Auwera, F Gorus, Bart O Roep, Sandrine Aspeslagh, Bart Neyns, et al.
Pages: 363-374 - PRIMMO study protocol(2019)
Authors: Sandra Tuyaerts, An Van Nuffel, Eline Naert, Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, et al.
- Immune checkpoint blockade for organ transplant patients with advanced cancer(2019)
Authors: Pauline De Bruyn, Dirk Van Gestel, Piet Ost, Vibeke Kruse, Lieve Brochez, Hans Van Vlierberghe, Arnaud Devresse, Véronique Del Marmol, Alain Le Moine, Sandrine Aspeslagh
Pages: 54-64 - Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation(2019)
Authors: Marie-Léa Gauci, Emilie Lanoy, Stéphane Champiat, Caroline Caramella, Samy Ammari, Sandrine Aspeslagh, Andrea Varga, Capucine Baldini, Rastilav Bahleda, Anas Gazzah, et al.
Pages: 946-956 - Immunotherapy in oncology(2019)
Authors: Sandrine Aspeslagh
Pages: 351-354 - Immuno-oncology-101(2018)
Authors: B Allard, Sandrine Aspeslagh, S Garaud, Fieke Dupont, Cinzia Solinas, Martelize Kok, B Routy, Christos Sotiriou, Charlotte J. Stagg, L Buisseret
Pages: 1-11 - Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma(2018)
Authors: Astrid De Meulenaere, Tijl Vermassen, David Creytens, Sandrine Aspeslagh, Philippe Deron, Frederic Duprez, Sylvie Rottey, Jo A Van Dorpe, Liesbeth Ferdinande
Pages: 500-509 - Cancer immunotherapy-associated hypophysitis(2018)
Authors: Cinzia Solinas, Michele Porcu, Pushpamali De Silva, Marco Musi, Sandrine Aspeslagh, Mario Scartozzi, Karen Willard-Gallo, Stefano Mariotti, Luca Saba
Pages: 181-186 - Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours(2018)
Authors: H Herin, Sandrine Aspeslagh, E Castanon, V Dyevre, Aurélien Marabelle, Andrea Varga, Sophie Postel-Vinay, Jean-Marie Michot, Vincent Ribrag, Anas Gazzah, et al.
Pages: 68-74